Mediclarum
Medicine guide

Dengvaxia

·

  • Prescription status not stated
  • Antibiotics, antivirals and antifungals taken into the body
Made by
Sanofi Winthrop Industrie

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

  • Dengvaxia is indicated for the prevention of dengue disease caused by dengue virus serotypes 1, 2, 3 and 4 in individuals 6 to 45 years of age with test-confirmed previous dengue infection (see sections 4.2, 4.4 and 4.8). The use of Dengvaxia should be in accordance with official recommendations.

From the official label · 2026-09-30 · European Medicines Agency

Details

Made bySanofi Winthrop Industrie
Active substanceDengue tetravalent vaccine (live, attenuated)
Used inAntibiotics, antivirals and antifungals taken into the body
ClassificationJ07BX · Antibiotics, antivirals and antifungals taken into the body
Authorised on2018-12-12
Last updated by the regulator2025-12-04
EMA product numberEMEA/H/C/004171

Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician

Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).

Report wrong or outdated information on this page

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.

QdengaEU authorisation Takeda Pharmaceuticals International AG Ireland Branch · Dengue tetravalent vaccine (live, attenuated) · J07BX04

See every product with Dengue tetravalent vaccine (live, attenuated)